Stablecoin Development Revenue Growth Rates (SDEV), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Stablecoin Development Corporation  (SDEV)
 

SDEV's Revenue Growth by Quarter and Year

Stablecoin Development's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/SDEV/growth
https://api.csimarket.com/api/v1/companies/SDEV/fundamentals
https://api.csimarket.com/api/v1/companies/SDEV/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
SDEV Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 2.14
2nd Quarter June 2.21
1st Quarter March 2.46
FY 6.81

SDEVs Annual Revenue
Stablecoin Development's Revenue in the fiscal year 2025 $ 0.00 millions
Stablecoin Development's Revenue in the fiscal year 2024 $ 9.48 millions
Stablecoin Development's Revenue in the fiscal year 2023 $ 13.90 millions
Stablecoin Development's Revenue in the fiscal year 2022 $ 13.78 millions
Stablecoin Development's Revenue in the fiscal year 2021 $ 8.42 millions




SDEV Revenue third quarter 2026 Y/Y Growth Comment
Stablecoin Development Corporation achieved in the third quarter 2026, above Company average Revenue surge of 311.54% year on year, to $ 2.14 millions.

Looking into third quarter 2026 results within Major Pharmaceutical Preparations industry 23 other companies have achieved higher Revenue growth. While Stablecoin Development Corporation' s Revenue doubling of 311.54% ranks overall at the positon no. 105 in the third quarter 2026.


SDEV Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 311.54 %
2nd Quarter June -
1st Quarter March -
FY   -

Financial Statements
Stablecoin Development's third quarter 2026 Revenue $ 2.14 millions SDEV's Income Statement
Stablecoin Development's third quarter 2025 Revenue $ 0.52 millions Quarterly SDEV's Income Statement


SDEV Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -3.17 %
2nd Quarter June -10.16 %
1st Quarter March 459.09 %
FY (Year on Year)   -


Back to SDEV Growth rate Comparisons >> Back to SDEV Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #24
Healthcare Sector #35
Overall #105

Revenue Y/Y Growth Statistics
High Average Low
3636.96 % 148.85 % -100 %
(Jun 30 2015)   (Mar 31 2025)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #24
Healthcare Sector #35
Overall #105
Revenue Y/Y Growth Statistics
High Average Low
3636.96 % 148.85 % -100 %
(Jun 30 2015)   (Mar 31 2025)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Stablecoin Development's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
2091.3 % 49.97 % -100 %
(Jun 30 2015)  


SDEV's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 Stablecoin Development Corporation disclosed fall in Revenue from the second quarter by -3.17% to $ 2.14 millions, from $ 2.21 millions achived in the previous reporting period.

Within Major Pharmaceutical Preparations industry 127 other companies have achieved higher Revenue quarter on quarter growth. While Stablecoin Development's Revenue growth quarter on quarter, overall rank is 2876.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #128
Healthcare Sector #366
Overall #2876
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #128
Healthcare Sector #366
Overall #2876
Revenue Q/Q Growth Statistics
High Average Low
2091.3 % 49.97 % -100 %
(Jun 30 2015)  


SDEV's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 Stablecoin Development Corporation disclosed fall in Revenue from the second quarter by -3.17% to $ 2.14 millions, from $ 2.21 millions achived in the previous reporting period.

Within Major Pharmaceutical Preparations industry 127 other companies have achieved higher Revenue quarter on quarter growth. While Stablecoin Development's Revenue growth quarter on quarter, overall rank is 2876.


Stablecoin Development's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2026)		 12 Months Ending (Jun 30 2026) 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025)
Cumulative Revenue 12 Months Ending $ 7.25
Y / Y Revenue Growth (TTM) -
Year on Year Revenue Growth Overall Ranking #
Seqeuential Revenue Change (TTM) 28.77 %
Seq. Revenue Growth (TTM) Overall Ranking #


Cumulative Revenue growth Comment
Stablecoin Development saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 311.54% year on year, to $ 7 millions if the fiscal year would have ended in Sep 30 2026.
Stablecoin Development's trailing twelve months Revenue growth was higher than company's average 0% and higher than % growth in Jun 30 2026. And, Stablecoin Development realized the fastest Revenue growth, in Major Pharmaceutical Preparations industry.
But from twelve months ended Jun 30 2026 rise was beneth at 28.77 % from $5.63 millions achieved in the period from Jun 30 2026 to Sep 30 2025.
We witness drop-off happening, more obvious observing the usual Q/Q TTM historic rise that is stronger at74.37%.

Stablecoin Development Corporation achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 58
Sector # 130
S&P 500 # 598
Cumulative Revenue growth Comment
Stablecoin Development saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 311.54% year on year, to $ 7 millions if the fiscal year would have ended in Sep 30 2026.
Stablecoin Development's trailing twelve months Revenue growth was higher than company's average 0% and higher than % growth in Jun 30 2026. And, Stablecoin Development realized the fastest Revenue growth, in Major Pharmaceutical Preparations industry.
But from twelve months ended Jun 30 2026 rise was beneth at 28.77 % from $5.63 millions achieved in the period from Jun 30 2026 to Sep 30 2025.
We witness drop-off happening, more obvious observing the usual Q/Q TTM historic rise that is stronger at74.37%.
The momentum is even more impressive from twelve months ended Jun 30 2026 exhibited at 28.77 % increase from $5.63 millions in the period from Jun 30 2026 to Sep 30 2025.

Stablecoin Development Corporation achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 58
Sector # 130
S&P 500 # 598




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
SDEV's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue fall for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Bio Green Med Solution Inc 460.49%$ 460.494 millions
Xencor Inc454.88%$ 454.884 millions
Tonix Pharmaceuticals Holding Corp 423.83%$ 423.830 millions
Nakamoto Inc 396.90%$ 396.897 millions
EBR Systems, Inc.385.65%$ 385.647 millions
Solana Company382.07%$ 382.066 millions
Pulse Biosciences Inc 359.30%$ 359.302 millions
Ensysce Biosciences Inc 342.43%$ 342.428 millions
Nexalin Technology Inc 331.43%$ 331.434 millions
Agios Pharmaceuticals Inc 330.01%$ 330.008 millions
Insmed Inc330.00%$ 330.000 millions
Monte Rosa Therapeutics Inc 325.80%$ 325.799 millions
Liquidia Corporation314.60%$ 314.596 millions
Stablecoin Development Corporation310.75%$ 310.749 millions
Renovorx Inc 300.75%$ 300.752 millions
Aligos Therapeutics Inc 281.92%$ 281.916 millions
Clene Inc 273.33%$ 273.333 millions
Recursion Pharmaceuticals Inc 258.49%$ 258.493 millions
Nuvation Bio Inc 251.98%$ 251.977 millions
Seastar Medical Holding Corp246.99%$ 246.995 millions
Prime Medicine Inc 243.92%$ 243.918 millions
Urogen Pharma Ltd 227.16%$ 227.161 millions
Dianthus Therapeutics Inc 205.56%$ 205.556 millions
Bridgebio Pharma Inc 192.60%$ 192.602 millions
Bicycle Therapeutics Plc190.24%$ 190.242 millions
Gossamer Bio Inc 189.09%$ 189.085 millions
Alpha Cognition Inc.173.75%$ 173.751 millions
Eton Pharmaceuticals Inc 165.04%$ 165.042 millions
Sera Prognostics Inc 162.50%$ 162.500 millions
Volitionrx Limited157.28%$ 157.283 millions


About Stablecoin Development Revenue Growth Rates (SDEV), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Stablecoin Development Corp (CIK 1389545).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001437749-26-033940
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Stablecoin Development Corp’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.